In fact, BACH2 variants were associated with diabetes type 1 in a study of genome-wide association (GWA) genotyping (Grant et al. 2020) and treatment with a BACH inhibitor lowered glycemia in a model of single cells of pancreatic islets from diabetes type 2 individuals (Son et al. 2021). Here, BACH2 is linked to type 1 diabetes mellitus.